AAAAAA
Results:
1-8
|
Results: 8
Authors:
ANTHONY LB
PETRYK L
OLEJARCZYK J
FOULDS EC
SCHRAN HF
Citation: Lb. Anthony et al., PHARMACOKINETICS OF OCTREOTIDE ACETATE LONG-ACTING RELEASE (OALAR) INVOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 29-29
Authors:
SCHRAN HF
PETRYK L
CHANG CT
OCONNOR R
GELBERT MB
Citation: Hf. Schran et al., THE PHARMACOKINETICS AND BIOAVAILABILITY OF CLEMASTINE AND PHENYLPROPANOLAMINE IN SINGLE-COMPONENT AND COMBINATION FORMULATIONS, Journal of clinical pharmacology, 36(10), 1996, pp. 911-922
Authors:
PICHARD L
DOMERGUE J
FOURTANIER G
KOCH P
SCHRAN HF
MAUREL P
Citation: L. Pichard et al., METABOLISM OF THE NEW IMMUNOSUPPRESSOR CYCLOSPORINE-G BY HUMAN LIVER CYTOCHROMES P450, Biochemical pharmacology, 51(5), 1996, pp. 591-598
Authors:
MANGOLD JB
SCHRAN HF
TSE FLS
Citation: Jb. Mangold et al., PHARMACOKINETICS AND METABOLISM OF CYCLOSPORINE-G IN HUMANS, Drug metabolism and disposition, 22(6), 1994, pp. 873-879
Authors:
MANGOLD JB
SCHRAN HF
YATSCHOFF RW
WEITZEL WF
LEICHTMAN AB
Citation: Jb. Mangold et al., BIOTRANSFORMATION OF CYCLOSPORINE-G IN COMPARISON TO CYCLOSPORINE (VOL 26, PG 3013, 1994), Transplantation proceedings, 26(6), 1994, pp. 3741-3741
Authors:
MANGOLD JB
SCHRAN HF
YATSCOFF RW
WEITZEL WF
LEICHTMAN AB
Citation: Jb. Mangold et al., BIOTRANSFORMATION OF CYCLOSPORINE-G IN COMPARISON TO CYCLOSPORINE, Transplantation proceedings, 26(5), 1994, pp. 3013-3016
Authors:
SCHRAN HF
TSE FLS
CHANG CT
HUNT TL
SAXE MA
VENTURA DF
DISERIO FJ
HENDLER J
Citation: Hf. Schran et al., BIOEQUIVALENCE AND SAFETY OF SUBCUTANEOUSLY AND INTRAMUSCULARLY ADMINISTERED DIHYDROERGOTAMINE IN HEALTHY-VOLUNTEERS, Current therapeutic research, 55(12), 1994, pp. 1501-1508
Authors:
SALLAS WM
SCHRAN HF
Citation: Wm. Sallas et Hf. Schran, LINEAR MIXED EFFECTS MODELS FOR TROUGH CONCENTRATIONS OF CYCLOSPORINE-A AND CYCLOSPORINE-G, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 162-162
Risultati:
1-8
|